Eywa Biotech founder and CEO Victoria Costa Paz explains why bringing psychedelic medicine into mainstream mental health care requires far more than producing pharmaceutical-grade psilocybin. She shares how Eywa is combining biosynthesis, patient tracking, professional education, and treatment infrastructure to build a system around a new model of mental health care.

See omnystudio.com/listener for privacy information.